Step'n Out: A Multisite Trial of Collaborative Behavioral Management for Drug-Involved Parolees
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The main purpose of this study is to examine whether improved integration between the community supervision system and outpatient addiction treatment system can improve treatment adherence, drug use and public safety outcomes among drug-involved inmates re-entering the community.
| Condition | Intervention |
|---|---|
|
Substance-Related Disorders |
Behavioral: Collaborative Behavioral Management Procedure: Integrated parole and outpatient addiction treatment |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Step'n Out: A Multisite Trial of Collaborative Behavioral Management for Drug-Involved Parolees |
- Rearrest
- Drug use
| Estimated Enrollment: | 420 |
| Study Start Date: | February 2005 |
| Estimated Study Completion Date: | August 2007 |
The target population consists of male and female parolees with a history of substance abuse treatment who are at moderate-to-high-risk of recidivism. They will recruited from in the criminal justice system and/or transitional residential drug treatment within one or two months of release or at the time they first report for parole supervision.
Participants from six states (KY, OR, RI, CT, VA, DE) will be randomized into the Step'n Out condition (integration of community supervision and addiction treatment with behavioral management) or a comparison condition including traditional community supervision and addiction treatment. Research interviews at baseline, and 3 and 9 months after release from confinement will assess study participants' outcomes.
The Step'n Out intervention will produce significantly better outcomes than the standard referral condition with respect to: recidivism rates (revocation, rearrest on a new charge, reconviction, reincarceration), as assessed 3 and 9 months after the end of the intervention; treatment participation (i.e., proportion of planned sessions attended, proportion of planned days retained in treatment, type of discharge [successful completion, transfer to another program, elopement, administrative discharge, return to custody], as assessed after the end of the intervention; self-reported drug use, criminal activity, and psychosocial functioning, as assessed 3 and 12 months after the end of the intervention; cost-effectiveness; collaboration between the supervision officer and treatment counselor ; and therapeutic alliance with the clients.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- be at least 18 years old and speak English;
- have probable drug dependence immediately prior to incarceration as determined by a score of 3 or higher on the TCU Drug Screen II;
- be at moderate-to-high-risk of drug relapse and/or recidivism as determined by a Lifestyle Criminality Screening Form (LCSF) score of 7 or greater, or a history of 2 or greater prior treatments for drug-related problems or drug-related convictions;
- must have substance use treatment as a mandated or recommended condition of parole.
Exclusion Criteria:
- psychotic features;
- parole or probation conditions that prohibit them from participating in the protocol.
Contacts and Locations| Contact: Peter D Friedmann, MD, MPH | 401-444-3347 | pfriedmann@lifespan.org |
| Contact: Kristina Richards, MA | 401-444-5838 | krichards@lifespan.org |
| United States, California | |
| University of California, Los Angeles | Recruiting |
| Los Angeles, California, United States, 90025 | |
| Contact: William Burdon, PhD 310-445-0874 ext 333 wburdon@ucla.edu | |
| Contact: Carter Bartee, BA 503-241-7145 cbartee@ucla.edu | |
| Principal Investigator: Michael Prendergast, PhD | |
| United States, Connecticut | |
| Connecticut Deptartment of Mental Health & Addiction Services | Recruiting |
| Hartford, Connecticut, United States, 06134 | |
| Contact: Eleni Rodis 860-418-6663 Eleni.Rodis@po.state.ct.us | |
| Principal Investigator: Linda K Frisman, PhD | |
| United States, Delaware | |
| University of Delaware | Recruiting |
| Newark, Delaware, United States, 19716 | |
| Contact: Daniel J O'Connell, PhD 302-831-4649 oconnell@UDel.Edu | |
| Principal Investigator: Steven S. Martin, PhD | |
| United States, Kentucky | |
| University of Kentucky | Not yet recruiting |
| Lexington, Kentucky, United States, 40536 | |
| Contact: Conrad J Wong, PhD 859-323-6774 conrad.wong@uky.edu | |
| Principal Investigator: Carl G Leukefeld, DSW | |
| United States, Virginia | |
| Virginia Commonwealth University | Not yet recruiting |
| Richmond, Virginia, United States, 23284 | |
| Contact: Anne G Rhodes, MA 804-827-1160 agrhodes@vcu.ed | |
| Contact: Melinda Gales (804) 628-0646 mgales@mail1.vcu.edu | |
| Principal Investigator: Faye S Taxman, PhD | |
| Principal Investigator: | Peter D Friedmann, MD, MPH | Rhode Island Hospital |
More Information
Additional Information:
No publications provided by National Institute on Drug Abuse (NIDA)
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| ClinicalTrials.gov Identifier: | NCT00302575 History of Changes |
| Other Study ID Numbers: | 1U01DA016191 |
| Study First Received: | March 13, 2006 |
| Last Updated: | February 1, 2010 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Institute on Drug Abuse (NIDA):
|
Substance-Related Disorders Prisoners |
Additional relevant MeSH terms:
|
Substance-Related Disorders Mental Disorders |
ClinicalTrials.gov processed this record on May 16, 2013